Hiroaki Kobayashi | Gynecology | Best Researcher Award

Prof. Hiroaki Kobayashi | Gynecology | Best Researcher Award

Dept. of Obstetrics and Gynecology,Faculty of Medicine, Kagoshima University | Japan

Hiroaki Kobayashi, M.D., Ph.D. is a leading figure in gynecologic oncology, currently serving as Professor and Chairman of Obstetrics & Gynecology at Kagoshima University (also Professor in the Course of Advanced Cancer Medicine for Gynecologic Cancer). His clinical expertise encompasses robot-assisted surgery, chemotherapy including molecular targeted agents, and translational research such as comprehensive genomic profiling and drug delivery systems. Educated at Kyushu University, with post-doctoral training in Canada, he has held senior academic positions across Japan, including roles directing robotic surgery centres and genetic counselling. He is deeply involved in professional societies in Japan and abroad, particularly those focused on gynecologic oncology and robotic surgery. According to institutional and bibliographic sources, he has authored approximately 248 published papers. The exact h-index and total citation count were not publicly confirmed in reliable sources as of the latest update. Nevertheless, his publication record shows consistent productivity with multiple highly cited works in top journals in his field, reflecting strong influence in gynecologic cancer research.

Profile: Orcid

Featured Publications 

Togami, S., Furuzono, N., Mizuno, M., & Kobayashi, H. (2025). Comparison of laparoscopic and robotic-assisted minimally invasive surgery with sentinel lymph node navigation in low-risk endometrial cancer: A retrospective analysis. Journal of Gynecologic Oncology, 36(e122).

Togami, S., Furuzono, N., Kobayashi, Y., Fukuda, M., Yanazume, S., & Kobayashi, H. (2025, October). Fertility‐sparing trachelectomy with sentinel node mapping in early‐stage cervical cancer: Oncological safety and obstetric outcomes from a single‐institution study. Journal of Obstetrics and Gynaecology Research.

Kozai, A., Yanazume, S., Ejima, F., Tatarano, S., Kobayashi, Y., Kubo, R., Togami, S., Yoshiura, T., & Kobayashi, H. (2025, August 1). Segmental renal infarction associated with accessory renal arteries after para-aortic lymphadenectomy in gynecologic malignancies. Medicina, 61(8), 1395.

Mizuno, M., Togami, S., Nakazono, M., Higashi, Y., Furuzono, N., Fukuda, M., & Kobayashi, H. (2025, July). Impact of obesity on the outcomes and cost of robotic surgery for stage IA endometrial cancer: A regional perspective from Japan. International Journal of Clinical Oncology.

Yanazume, S., Ejima, F., Kobayashi, Y., Kozai, A., Fukuda, M., Togami, S., Yoshiura, T., & Kobayashi, H. (2025, July). Potential preoperative three‐dimensional computed tomography for para‐aortic lymphadenectomy in gynecological malignancies. Journal of Obstetrics and Gynaecology Research.

Prof. Mrinal k ghosh  – Cancer Therapy – Outstanding Scientist Award

Prof. Mrinal k ghosh  - Cancer Therapy - Outstanding Scientist Award

CSIR-Indian Institute of Chemical Biology - India 

Author Profile 

SCOPUS 

🎓 Early academic pursuits

Dr. Mrinal k ghosh earned his b.sc., m.sc., and phd in biochemistry from the university of calcutta, india. his academic journey was characterized by a strong foundation in molecular biology and biochemistry, leading to a prolific research career in cancer biology and inflammatory disorders.

🏢 Professional endeavors

Dr. Ghosh has held various prestigious positions at csir-indian institute of chemical biology, culminating in his current role as chief scientist. his international experience includes post-doctoral research at the cleveland clinic foundation, usa, and academic roles in india, contributing significantly to cancer research and molecular biology.

🔄 Contributions and research focus

Specializing in cancer biology and inflammatory disorders, dr. ghosh has developed groundbreaking research in signal transduction in cancer and stem cells. his work has led to numerous Cancer Therapy publications, patents, and collaborative projects that have advanced the understanding and treatment of cancer.

🏆 Accolades and recognition

His numerous accolades include the bharat vikash award, fellowships from the national academy of science and technology, and the outstanding scientist award. his role as a reviewer for top Cancer Therapy journals and evaluator for national and international projects further highlights his academic stature.

👨‍👩‍👦 Impact and influence

Dr. Ghosh's influence extends beyond his research, impacting policy-making, academic standards, and translational research in india. his leadership roles within csir-iicb and various academic Cancer Therapy committees have shaped the future of scientific research in the country.

🌟 Legacy and future contributions

Dr. Ghosh's legacy is defined by his contributions to cancer biology, his mentorship of future scientists, and his commitment to advancing biomedical research. his ongoing work promises continued innovation and significant contributions to cancer therapy and molecular biology.

Notable Publications 

  • Title: The key vulnerabilities and therapeutic opportunities in the USP7-p53/MDM2 axis in cancer
    Author(s): Gouranga Saha, Mrinal Kanti Ghosh
    Journal: BBA - Molecular Cell Research, 2025

  • Title: Phenolato and alkoxo promoted change in the ligand coordination mode in a four-membered ortho-metalated ruthenium(II) organometallics
    Author(s): Mrinal Kanti Ghosh, Jagannath Chowdhury, Purnananda Garu, Indranil Chakraborty, Swarup Chattopadhyay
    Journal: Polyhedron, 2025

  • Title: Carbon Nanotubes in Cancer Diagnosis and Treatment: Current Trends and Future Perspectives
    Author(s): Sunny Kumar, Aafreen Ansari, Malini Basu, Sabana Begam, Mrinal Kanti Ghosh
    Journal: Advanced Therapeutics, 2025

  • Title: E3 ubiquitin ligases and deubiquitinases in colorectal cancer: Emerging molecular insights and therapeutic opportunities
    Author(s): Sunny Kumar, Malini Basu, Mrinal Kanti Ghosh
    Journal: BBA - Molecular Cell Research, 2024

  • Title: Chromosomal instability (CIN) triggers immune evasion and metastatic potential in cancer through rewired STING signalling
    Author(s): Mrinal Kanti Ghosh, Srija Roy
    Journal: Molecular Biomedicine, 2024